All In MedTech

Device Trial Radar · NCT05046158

Diabetic Foot Ulcers-Comparing Transforming Powder to Standard of Care

Randomized Clinical Trial to Compare Transforming Powder and Standard of Care Dressing Therapies to Heal Diabetic Foot Ulcers

Last checked: Nov 19, 2026Latest source record: Nov 19, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 135 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

135

Actual

Start

Aug 16, 2021

Primary completion

Nov 6, 2025

Study completion Nov 6, 2025

Sponsor

Lead sponsor
ULURU Inc.Not on our public-company list
Sponsor type
Industry
Collaborators
Naval Medical Research Center; Military Technology Enterprise Consortium (US)
First posted
Sep 16, 2021

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 18 years, up to 89 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Phase IV, randomized, prospective, multi-center, open-label, comparison of transforming powder dressing to standard of care dressing for healing diabetic foot ulcers.

Conditions

  • Diabetic Foot Ulcer

Interventions

  • Transforming Powder DressingDevice

    Altrazeal transforming powder dressing is methacrylate-based powder dressing made from the same materials used in the production of contact lenses. Upon hydration, the powder transforms into a moist, non-occlusive barrier that covers and protects the wound from exogenous bacteria while helping manage exudate through vapor transpiration.

  • Standard of care topical wound agents and dressingsOther

    Standard wound dressings such as gauze or foams. Moisture regulating topical agents may also be used to prepare the wound bed.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Incidence of wound closureTime frame: 12 weeks

Locations

12 sites in 1 country. Site status is shown where the registry gives one.

  • MedStar Georgetown University Hospital

    Washington D.C., District of Columbia

  • MedStar Washington Hospital Center

    Washington D.C., District of Columbia

  • AdventHealth Medical Group Foot & Ankle at Winter Park

    Winter Park, Florida

9 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.